-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-203-fullreport.pdf
April 10, 2017 - Initial Risk Assessment for Immobility-Related Pressuer Ulcer Within 24 Hours of Pediatric Intensive Care Unit (PICU) Admission
Initial Risk Assessment for Immobility-Related
Pressure Ulcer Within 24 Hours of Pediatric Intensive
Care Unit (PICU) Admission
Section 1. Basic Measure Information
1.A. Measure Name
In…
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/making-healthcare-safer/mhs3/failure-to-rescue-1.pdf
March 01, 2020 - Chapter-2 - Failure-To-Rescue
Failure To Rescue 2-1
2. Failure To Rescue
Authors: Kendall K. Hall, M.D., M.S., Andrea Lim, and Bryan Gale, M.A.
Introduction
Background
Failure to rescue (FTR) is failure or delay in recognizing and responding to a hospitalized patient
experiencing complications from a disease p…
-
www.ahrq.gov/sites/default/files/publications2/files/dxsafety-issuebrief-education.pdf
March 11, 2022 - Issue Brief 7. Improving Education: A Key to Better Diagnostic Outcomes
Issue Brief 7
Improving Education—A Key to
Better Diagnostic Outcomes
PATIENT
SAFETY
e
This page intentionally left blank.
e
Issue Brief 7
Improving Education—A Key to Better
Diagnostic Outcomes
Prepared for:
Agency for Healthcare…
-
www.ahrq.gov/sites/default/files/wysiwyg/sops/surveys/medical-office/2022-MOSOPS-Database-Report-Part-II-508.pdf
January 01, 2022 - office an Overall Rating on Patient Safety of “Excellent” or “Very good” (79 percent);
Physician Assistant
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/making-healthcare-safer/mhs3/sepsis-1.pdf
March 01, 2020 - Chapter-3 - Sepsis Recognition
Sepsis Recognition 3-1
3. Sepsis Recognition
Authors: Bryan Gale, M.A., and Kendall K. Hall, M.D., M.S.
Introduction
Sepsis has been a leading cause of hospitalization and death in U.S. healthcare settings for many years,
and accounts for more hospital admissions and spending than…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/duration/chipra-154-fullreport.pdf
July 01, 2018 - Continuity of Insurance: Coverage Presumed Eligible
1
Continuity of Insurance: Coverage Presumed Eligible
Section 1. Basic Measure Information
1.A. Measure Name
Continuity of Insurance: Coverage Presumed Eligible
1.B. Measure Number
0154
1.C. Measure Description
Please provide a non-technical descripti…
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/final-reports/22458-Rosenman-report.pdf
October 01, 2018 - Final Report: Translating simulation-based team leadership training into patient-level outcomes
Title of Project: Translating simulation-based team leadership training into patient-level outcomes
Principal Investigator and Team Members: Fernandez, R (PI); Rosenman, ED (Site PI); Nichol,
G; Arbabi, S; Chao, GT
O…
-
www.ahrq.gov/sites/default/files/2024-01/fernandez-rosenman-report.pdf
January 01, 2024 - Final Report: Translating simulation-based team leadership training into patient-level outcomes
Title of Project: Translating simulation-based team leadership training into patient-level outcomes
Principal Investigator and Team Members: Fernandez, R (PI); Rosenman, ED (Site PI); Nichol,
G; Arbabi, S; Chao, GT
O…
-
www.ahrq.gov/sites/default/files/2024-10/kennerly-ballard-report.pdf
January 01, 2024 - Final Progress Report: Adverse Event-Directed Analysis in Ambulatory Primary Care
Adverse Event-Directed Analysis in Ambulatory Primary
Care Final Report
September 30, 2009
Principal Investigator: Donald Kennerly, MD, PhD
Team Members:
David Ballard, MD, MSPH, PhD, Co-Investigator
S. Quay Mercer, BS, MT (ASCP…
-
www.ahrq.gov/sites/default/files/2024-02/cohen2-report.pdf
January 01, 2024 - Final Progress Report: Risk-Informed Interventions in Community Pharmacy: Implementation and Evaluation
Final Report:
Risk-Informed Interventions in Community Pharmacy:
Implementation and Evaluation
Principal Investigator:
Michael R. Cohen, RPh, MS, ScD (hon), DPS (hon)
Team Members:
Judy L. Smetzer, RN, BSN,…
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/hais/tools/mvp/modules/vae/datameasures-guide.pdf
January 01, 2017 - Data Measures Guide
AHRQ Safety Program for
Mechanically Ventilated Patients
Data Measures Guide
AHRQ Pub. No. 16(17)-0018-6-EF
January 2017
Data Measures Guide
Introduction ....................................................................................................................…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-0242-fullreport.pdf
February 01, 2020 - Follow-up Visits for Children Who Are Obese or Overweight with a Weight-Related Comorbidity: Report
1
Follow-up Visits for Children Who Are Obese or
Overweight with a Weight-Related Comorbidity
Section 1. Basic Measure Information
1.A. Measure Name
Follow-up Visits for Children Who Are Obese or Overweight wi…
-
www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/measure_retirement/supplemental-materials/supplementaldoc3.pdf
September 01, 2014 - 2013 Child Core Set Measure Retirement Process Summary of SNAC Scoring: Round II – Final Scoring
The findings and conclusions in this document are those of the author(s), who are responsible for its
content, and do not necessarily represent the views of AHRQ and the Centers for Medicare & Medicaid
Services (CMS). N…
-
www.ahrq.gov/sites/default/files/2024-07/ashton-report.pdf
January 01, 2024 - Final Progress Report: Racial and Ethnic Variations in Medical Interactions
Title of Project
Racial and Ethnic Variations in Medical Interactions
Principal Investigator and Team Members
Carol M. Ashton, MD, MPH (PI), Tracie C. Collins, MD, MPH, Coreen Domingo, MPH, Howard S. Gordon,
MD…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/duration/chipra-155-fullreport.pdf
September 01, 2018 - Continuity of Insurance: Coverage Presumed Ineligible
1
Continuity of Insurance: Coverage Presumed
Ineligible
Section 1. Basic Measure Information
1.A. Measure Name
Continuity of Insurance: Coverage Presumed Ineligible
1.B. Measure Number
0155
1.C. Measure Description
Please provide a non-technical d…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/duration/chipra-153-fullreport.pdf
May 23, 2018 - Continuity of Insurance: Informed Participation
1
Continuity of Insurance: Informed Participation
Section 1. Basic Measure Information
1.A. Measure Name
Continuity of Insurance: Informed Participation
1.B. Measure Number
0153
1.C. Measure Description
Please provide a non-technical description of the me…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/duration/chipra-156-fullreport.pdf
June 01, 2018 - Continuity of Insurance: Duration of First Observed Enrollment
1
Continuity of Insurance: Duration of First Observed
Enrollment
Section 1. Basic Measure Information
1.A. Measure Name
Continuity of Insurance: Duration of First Observed Enrollment
1.B. Measure Number
0156
1.C. Measure Description
Please …
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-208-fullreport.pdf
May 13, 2019 - Neonatal Intensive Care All-Condition Readmissions Without Gestational Age: Full Report
Neonatal Intensive Care All-Condition Readmissions
Without Gestational Age
Section 1. Basic Measure Information
1.A. Measure Name
Neonatal Intensive Care All-Condition Readmissions Without Gestational Age
1.B. Measure Number…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-134-fullreport.pdf
November 01, 2019 - Availability of Multidisciplinary Outpatient Care for Women with High-Risk Pregnancies
Availability of Multidisciplinary Outpatient Care for
Women with High-Risk Pregnancies
Section 1. Basic Measure Information
1.A. Measure Name
Availability of Multidisciplinary Outpatient Care for Women with High-Risk Pregnancie…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-233-fullreport.pdf
August 07, 2018 - Assessing the Availability of the Preconception Component of High-Risk Obstetrical Services by Estimating the Use of Teratogenic Medications Before and During Pregnancy
1
Assessing the Availability of the Preconception
Component of High-Risk Obstetrical Services by
Estimating the Use of Teratogenic Medications B…